Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce.
Qian LiCarolina E HagbergHelena Silva CascalesShuai LangMervi T HyvönenFiroozeh SalehzadehPing ChenIda AlexanderssonEleni TerezakiMatthew J HarmsMaria KutschkeNahida ArifenNiels KrämerMyriam AouadiCarole KnibbeJeremie BoucherAnders ThorellKirsty L SpaldingPublished in: Nature medicine (2021)
Obesity is considered an important factor for many chronic diseases, including diabetes, cardiovascular disease and cancer. The expansion of adipose tissue in obesity is due to an increase in both adipocyte progenitor differentiation and mature adipocyte cell size. Adipocytes, however, are thought to be unable to divide or enter the cell cycle. We demonstrate that mature human adipocytes unexpectedly display a gene and protein signature indicative of an active cell cycle program. Adipocyte cell cycle progression associates with obesity and hyperinsulinemia, with a concomitant increase in cell size, nuclear size and nuclear DNA content. Chronic hyperinsulinemia in vitro or in humans, however, is associated with subsequent cell cycle exit, leading to a premature senescent transcriptomic and secretory profile in adipocytes. Premature senescence is rapidly becoming recognized as an important mediator of stress-induced tissue dysfunction. By demonstrating that adipocytes can activate a cell cycle program, we define a mechanism whereby mature human adipocytes senesce. We further show that by targeting the adipocyte cell cycle program using metformin, it is possible to influence adipocyte senescence and obesity-associated adipose tissue inflammation.
Keyphrases
- cell cycle
- adipose tissue
- insulin resistance
- high fat diet induced
- cell proliferation
- high fat diet
- endothelial cells
- stress induced
- cardiovascular disease
- type diabetes
- metabolic syndrome
- weight loss
- quality improvement
- skeletal muscle
- weight gain
- glycemic control
- single cell
- squamous cell carcinoma
- rna seq
- circulating tumor cells
- body mass index
- fatty acid
- oxidative stress
- pluripotent stem cells
- circulating tumor
- binding protein
- cell therapy
- dna damage
- stem cells